Clinical Practice Guidelines

CSPT is endorsing relevant clinical practice guidelines.  "Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers" is posted below. 

Members are asked to review this document and send your comments directly to Dr. Bruce Carleton via email: bcarleton@popi.ubc.ca by February 15th, 2017.

 

Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers